Which spinal drug gets you home faster after anal surgery?
NCT ID NCT07156968
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tested whether adding fentanyl or dexmedetomidine to a standard spinal anesthetic (prilocaine) could shorten recovery time for people having day-case anal surgery. 159 adults participated. Researchers measured how quickly sensation returned and when patients were ready to go home. The goal is to find the best drug combination for a smoother, faster recovery.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- bupivacaine-fentanyl and prilocaine-dexmedetomidine
- What this could lead to
- If successful, this could help doctors choose the best spinal drug combination to speed up recovery and discharge after minor anal surgery.
- What could go wrong
- This is a small, completed study with no phase designation, so results may not apply broadly. The drugs carry risks like urinary retention or allergic reactions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
159 people
The number who actually took part.
- Started
-
Jan 2022
- Finished
-
May 2023
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 70 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Ages 18-70 * ASA 1-3 * height \<155cm or \>175cm * Day case perianal surgery Exclusion Criteria: * Hypersensitivity to the study drugs * Refusal of patients. * Patients with contraindications for spinal anesthesia * previous voiding difficulty * patients taking anticholinergic medications. * emergency cases * Patients with contraindications for day case sitting.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Effect of drug are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Faculty of Medicine Ain Shams University
Cairo, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Scientists pinpoint ideal sedative dose for sleep apnea scopes
- Asthma drug may boost some athletes – study investigates
- New sedative could keep ICU patients calmer on ventilators
- Which sedative works best for ventilator patients? new trial aims to find out
- Small study pinpoints ideal sedation dose for colonoscopy
- New drug combo shows promise for tough head and neck cancers